Serial Number 90601140
606

Registration Progress

Application Filed
Mar 24, 2021
Under Examination
Feb 8, 2022
Approved for Publication
Dec 14, 2021
Published for Opposition
Dec 14, 2021
Registered

Trademark Image

Basic Information

Serial Number
90601140
Filing Date
March 24, 2021
Published for Opposition
December 14, 2021
Abandonment Date
March 11, 2024
Drawing Code
2

Status Summary

Current Status
Inactive
Status Code
606
Status Date
Mar 11, 2024
Classes
005

Rights Holder

Travere Therapeutics, Inc.

03
Address
Suite 300
3611 Valley Centre Drive
San Diego, CA 92130

Ownership History

Travere Therapeutics, Inc.

Original Applicant
03
San Diego, CA

Travere Therapeutics, Inc.

Owner at Publication
03
San Diego, CA

Legal Representation

Attorney
Jared M. Barrett

USPTO Deadlines

All Deadlines Cleared

All 2 deadline(s) have been cleared by subsequent events. No active deadlines at this time.

Application History

27 events
Date Code Type Description Documents
Mar 11, 2024 MAB6 E ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED Loading...
Mar 11, 2024 ABN6 S ABANDONMENT - NO USE STATEMENT FILED Loading...
Jul 26, 2023 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Jul 24, 2023 EX3G S SOU EXTENSION 3 GRANTED Loading...
Jul 24, 2023 EXT3 S SOU EXTENSION 3 FILED Loading...
Jul 24, 2023 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Feb 10, 2023 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Feb 8, 2023 EX2G S SOU EXTENSION 2 GRANTED Loading...
Feb 8, 2023 EXT2 S SOU EXTENSION 2 FILED Loading...
Feb 8, 2023 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Jul 23, 2022 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Jul 21, 2022 EX1G S SOU EXTENSION 1 GRANTED Loading...
Jul 21, 2022 EXT1 S SOU EXTENSION 1 FILED Loading...
Jul 21, 2022 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Feb 8, 2022 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Dec 14, 2021 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Dec 14, 2021 PUBO A PUBLISHED FOR OPPOSITION Loading...
Nov 24, 2021 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Nov 5, 2021 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Nov 5, 2021 GNEN O NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Loading...
Nov 5, 2021 GNEA F EXAMINERS AMENDMENT E-MAILED Loading...
Nov 5, 2021 XAEC I EXAMINER'S AMENDMENT ENTERED Loading...
Nov 5, 2021 CNEA R EXAMINERS AMENDMENT -WRITTEN Loading...
Oct 29, 2021 DOCK D ASSIGNED TO EXAMINER Loading...
Jun 30, 2021 MDSC E NOTICE OF DESIGN SEARCH CODE E-MAILED Loading...
Jun 29, 2021 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Mar 27, 2021 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
pharmaceutical preparations for the treatment of kidney disease; pharmaceutical preparations for the treatment of focal segmental glomerulosclerosis (FSGS); pharmaceutical preparations for the treatment of Immunoglobulin A Nephropathy (IgAN); pharmaceutical preparations for the treatment of Alport Syndrome

Additional Information

Design Mark
The mark consists of a circle with interlocking halves having interdigitated fingers.

Classification

International Classes
005